1. Home
  2. FOLD

as 05-30-2025 3:36pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

Founded: 2002 Country:
United States
United States
Employees: N/A City: PRINCETON
Market Cap: 2.9B IPO Year: 2007
Target Price: $16.22 AVG Volume (30 days): 5.3M
Analyst Decision: Buy Number of Analysts: 10
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.10 EPS Growth: N/A
52 Week Low/High: $5.81 - $12.65 Next Earning Date: 05-01-2025
Revenue: $543,141,000 Revenue Growth: 28.25%
Revenue Growth (this year): 19.85% Revenue Growth (next year): 23.50%

FOLD Daily Stock ML Predictions

Share on Social Networks: